JP4555472B2 - ブタのウイルス疾患の処置 - Google Patents

ブタのウイルス疾患の処置 Download PDF

Info

Publication number
JP4555472B2
JP4555472B2 JP2000534220A JP2000534220A JP4555472B2 JP 4555472 B2 JP4555472 B2 JP 4555472B2 JP 2000534220 A JP2000534220 A JP 2000534220A JP 2000534220 A JP2000534220 A JP 2000534220A JP 4555472 B2 JP4555472 B2 JP 4555472B2
Authority
JP
Japan
Prior art keywords
pig
pigs
tilmicosin
virus
sirsv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2000534220A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002505294A (ja
JP2002505294A5 (enExample
Inventor
グレゴリー・アラン・アームブラスター
Original Assignee
イーライ リリー アンド カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by イーライ リリー アンド カンパニー filed Critical イーライ リリー アンド カンパニー
Publication of JP2002505294A publication Critical patent/JP2002505294A/ja
Publication of JP2002505294A5 publication Critical patent/JP2002505294A5/ja
Application granted granted Critical
Publication of JP4555472B2 publication Critical patent/JP4555472B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
JP2000534220A 1998-03-02 1999-03-02 ブタのウイルス疾患の処置 Expired - Fee Related JP4555472B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7646698P 1998-03-02 1998-03-02
US60/076,466 1998-03-02
PCT/US1999/004621 WO1999044619A1 (en) 1998-03-02 1999-03-02 Treatment of viral disease in swine

Publications (3)

Publication Number Publication Date
JP2002505294A JP2002505294A (ja) 2002-02-19
JP2002505294A5 JP2002505294A5 (enExample) 2006-04-13
JP4555472B2 true JP4555472B2 (ja) 2010-09-29

Family

ID=22132217

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000534220A Expired - Fee Related JP4555472B2 (ja) 1998-03-02 1999-03-02 ブタのウイルス疾患の処置

Country Status (16)

Country Link
US (1) US6034070A (enExample)
EP (1) EP0948967B1 (enExample)
JP (1) JP4555472B2 (enExample)
AT (1) ATE281173T1 (enExample)
AU (1) AU2979899A (enExample)
CA (1) CA2322327C (enExample)
CO (1) CO5080775A1 (enExample)
DE (1) DE69921530T2 (enExample)
DK (1) DK0948967T3 (enExample)
ES (1) ES2230802T3 (enExample)
MY (1) MY124071A (enExample)
PT (1) PT948967E (enExample)
SI (1) SI0948967T1 (enExample)
TW (1) TW565452B (enExample)
WO (1) WO1999044619A1 (enExample)
ZA (1) ZA991641B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506885B1 (en) * 2001-09-27 2003-01-14 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies to the drug tilmicosin and a method for detecting the same
WO2003034988A2 (en) * 2001-10-19 2003-05-01 Idexx Laboratories, Inc. Injectable compositions for the controlled delivery of pharmacologically active compound
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
ATE452896T1 (de) 2002-03-12 2010-01-15 Bristol Myers Squibb Co C3-cyanoepothilonderivate
US7282487B2 (en) * 2004-10-28 2007-10-16 Idexx Laboratories Method for treating bacterial infections in horses or pigs with tilmicosin
PL2089408T3 (pl) 2006-07-28 2012-03-30 Intervet Int Bv Sposób syntezy makrolidu
CN103288904B (zh) * 2013-06-28 2015-07-15 宁夏泰瑞制药股份有限公司 一种磷酸替米考星晶体的制备方法
CN103483406A (zh) * 2013-09-25 2014-01-01 宁夏泰瑞制药股份有限公司 一种磷酸替米考星的制备方法
CN103923141B (zh) * 2014-04-21 2016-04-27 西南大学 一种依托替米考星的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561147B2 (en) * 1982-09-13 1987-04-30 Eli Lilly And Company 20-amino macrolide antibiotics
US4820695A (en) * 1982-09-13 1989-04-11 Eli Lilly And Company C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics
US5574020A (en) * 1989-09-28 1996-11-12 Eli Lilly And Company Tilmicosin formulation
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
DK53595A (da) * 1994-05-13 1995-11-14 Iberica Cyanamid Rekombinante PRRSV-proteiner, diagnostiske kits og vaccine indeholdende sådanne rekombinante PRRSV-proteiner
DK0732340T3 (da) * 1995-03-14 2004-10-25 Akzo Nobel Nv Ekspression af porcine reproduktions- og respirationssyndromviruspolypeptider i den samme celle

Also Published As

Publication number Publication date
DE69921530D1 (de) 2004-12-09
DK0948967T3 (da) 2005-02-14
JP2002505294A (ja) 2002-02-19
ZA991641B (en) 2000-09-01
MY124071A (en) 2006-06-30
SI0948967T1 (en) 2005-06-30
PT948967E (pt) 2005-02-28
CO5080775A1 (es) 2001-09-25
CA2322327A1 (en) 1999-09-10
ES2230802T3 (es) 2005-05-01
AU2979899A (en) 1999-09-20
DE69921530T2 (de) 2005-10-27
US6034070A (en) 2000-03-07
CA2322327C (en) 2009-12-22
EP0948967B1 (en) 2004-11-03
ATE281173T1 (de) 2004-11-15
EP0948967A3 (en) 1999-10-20
EP0948967A2 (en) 1999-10-13
TW565452B (en) 2003-12-11
WO1999044619A1 (en) 1999-09-10

Similar Documents

Publication Publication Date Title
US10668144B2 (en) European PRRSV strain
Kyriakis et al. The effects of immuno-modulation on the clinical and pathological expression of postweaning multisystemic wasting syndrome
RS54239B1 (sr) C-28 amidi modifikovanih derivata c-3 betulinske kiseline kao inhibitori sazrevanja hiv-a
JP4555472B2 (ja) ブタのウイルス疾患の処置
KR101929141B1 (ko) 돼지 사료에서의 나라신의 항바이러스 효과
JP7564414B1 (ja) 卵巣卵胞の成長と発育の促進及び排卵誘発剤の製造におけるサリドロシドの使用
Higgins et al. The epidemiology and control of an outbreak of camel pox in Bahrain
McCauley et al. Disease problems in cattle associated with rations containing high levels of iodide
CN116687947B (zh) 柴胡皂苷d在制备抗猪伪狂犬病毒药物中的用途
US3336190A (en) Method of protecting the offspring of a herd of breeding swine from turbinate atrophy
CN119569671A (zh) Gw4064在制备抗猪蓝耳病毒药物中的应用
CN118742312A (zh) 不育剂组合物、试剂盒及其使用方法
Alexopoulos et al. The effect of vaccination of sows with an attenuated PRRSV vaccine an their health status and performance in a farm with endemic PRRSV infection
CN118141814A (zh) 铁螯合剂dfp在制备prrs防治药物中的应用
JP2023516706A (ja) ＳＡＲＳ－ＣｏＶ－２阻害におけるジメチルベルバミン化合物の適用
SNIJDERS et al. TRIALS WITH RAFOXANIDE
Wilson et al. Mechanistic aspects of fetal development relating to postnatal health and metabolism in pigs
Hoover Studies on the pathogenicity of feline herpes virus and feline leukemia virus
Wilson Effect of Dexamethasone and Equine Rhinopneumonitis Virus on Adrenocortical and Immunological Responses of Foals
Svoboda Poster-abstracts presented at the 2006: WSAVA/FECAVA/CSAVA World Congress.
JPH11509087A (ja) 病原性の低いｐｒｒｓ生ウイルスワクチン、ならびにその製造方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060220

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060220

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20090917

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090924

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20091020

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20091020

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091202

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20091202

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100706

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100716

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130723

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees